Posted by Michael Wonder on 13 Feb 2025
NICE joins international collaboration on HTA methods research
12 February 2025 - We’ve partnered with the US based ICER and the Canadian Drug Agency (CDA-AMC) to establish the Health Economics Methods Advisory (HEMA), a new international initiative to research and evaluate health technology assessment methods.
HEMA’s aim is to critically and independently research some of the most pressing topics in global health economics and health technology assessment methods. The collaboration brings together leading research experts and academics in health economics. A steering committee of patient representatives and life sciences professionals from the three countries will guide the selection and prioritisation of research topics.
